← Leaderboards
Igor O. Nasonkin
Biotime, Inc.
$743,605
Attributed
$2,230,814
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $816.8K · FY2017–19$1M$750K$500K$250K$0
'17
'18
'19
Funding mix
By agency
NIH$2,230,814 · 1
By mechanism
R44$2,230,814 · 1
Top collaborators
- Simon Petersen-Jones3 shared
- Magdalene J Seiler3 shared
Others in their field
Other Emerging Leaders on “Felis Catus”
- Robert A Gaunt · University Of Chicago$6,119,427
- Evan Snitkin · University Of Michigan At Ann Arbor$3,116,726
- Weizhe Hong · University Of California Los Angeles$2,751,192
- Victor Wang · Care.Coach Corporation$2,270,031
- Stephanie Laura Grainger · University Of California, San Diego$2,150,000
- Cristian A Linte · Rochester Institute Of Technology$1,788,290
Research focus
Felis CatusGanglion CellCyclic GmpEthicsFetalFrightAffectCostEarly OnsetEmotionalAnimals3-DimensionalAge Related Macular DegenerationBlindBlindnessBaseAmericanCell TherapyAnimal ModelCessation Of LifeClinical ProtocolsClinical TrialsCohortHuman Embryonic Stem Cell
Grant awards (3)
Retinal tissue derived from human pluripotent stem cells for vision restoration$670,621
R44 · FY2019 · EY · contact PI
Retinal tissue derived from human pluripotent stem cells for vision restoration$743,345
R44 · FY2018 · EY · contact PI
Retinal tissue derived from human pluripotent stem cells for vision restoration$816,848
R44 · FY2017 · EY · contact PI